Apotheek Fevery: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Apotheek Fevery
Largest movements
- Tangible fixed assets +€398,968
up €398,968 (+162%), from €246,526 to €645,495
of which Land and buildings: +€422,602
- Cash +€44,805
up €44,805 (+43.8%), from €102,325 to €147,130
mainly Debts after one year (+€402,286) and Depreciation (+€84,808)
- Receivables within one year +€24,241
up €24,241 (+29.8%), from €81,245 to €105,486
of which Trade receivables: +€26,401
- Debts after one year +€402,286
up €402,286 (+536%), from €75,000 to €477,286
- Trade debts +€28,412
up €28,412 (+44.1%), from €64,400 to €92,811
- Current portion of long-term debt +€22,714
new in 2025: €22,714
- Reserves +€12,512
up €12,512 (+6.2%), from €200,668 to €213,179
- Depreciation +€64,529
up €64,529 (+318%), from €20,280 to €84,808
- Staff costs -€36,295
down €36,295 (-48.1%), from €75,500 to €39,205
- Taxes -€3,822
down €3,822 (-41.0%), from €9,314 to €5,491
- Financial charges +€2,335
up €2,335 (+55.0%), from €4,242 to €6,577
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €634,338 | €1,092,793 | +€458,454 | +72.3% |
| Fixed assets | 21/28 | €246,526 | €645,495 | +€398,968 | +162% |
| Tangible fixed assets | 22/27 | €246,526 | €645,495 | +€398,968 | +162% |
| Land and buildings | 22 | €91,610 | €514,213 | +€422,602 | +461% |
| Plant, machinery and equipment | 23 | €131,087 | €114,961 | -€16,126 | -12.3% |
| Furniture and vehicles | 24 | €23,829 | €16,321 | -€7,508 | -31.5% |
| Current assets | 29/58 | €387,812 | €447,298 | +€59,486 | +15.3% |
| Stocks and contracts in progress | 3 | €200,121 | €193,612 | -€6,508 | -3.3% |
| Stocks | 30/36 | €200,121 | €193,612 | -€6,508 | -3.3% |
| Amounts receivable within one year | 40/41 | €81,245 | €105,486 | +€24,241 | +29.8% |
| Trade receivables | 40 | €67,082 | €93,482 | +€26,401 | +39.4% |
| Other amounts receivable | 41 | €14,163 | €12,003 | -€2,160 | -15.2% |
| Cash at bank and in hand | 54/58 | €102,325 | €147,130 | +€44,805 | +43.8% |
| Deferred charges and accrued income | 490/1 | €4,121 | €1,070 | -€3,052 | -74.0% |
| Total equity and liabilities | 10/49 | €634,338 | €1,092,793 | +€458,454 | +72.3% |
| Equity | 10/15 | €480,668 | €493,179 | +€12,512 | +2.6% |
| Contributions | 10/11 | €280,000 | €280,000 | = | 0.0% |
| Reserves | 13 | €200,668 | €213,179 | +€12,512 | +6.2% |
| Distributable reserves | 133 | €200,668 | €213,179 | +€12,512 | +6.2% |
| Amounts payable | 17/49 | €153,671 | €599,613 | +€445,943 | +290% |
| Amounts payable after more than one year | 17 | €75,000 | €477,286 | +€402,286 | +536% |
| Financial debts | 170/4 | €75,000 | €477,286 | +€402,286 | +536% |
| Amounts payable within one year | 42/48 | €76,809 | €122,064 | +€45,255 | +58.9% |
| Current portion of amounts payable after more than one year | 42 | - | €22,714 | +€22,714 | |
| Financial debts | 43 | €9,400 | - | -€9,400 | |
| Credit institutions | 430/8 | €9,400 | - | -€9,400 | |
| Trade debts | 44 | €64,400 | €92,811 | +€28,412 | +44.1% |
| Suppliers | 440/4 | €64,400 | €92,811 | +€28,412 | +44.1% |
| Taxes, remuneration and social security | 45 | €2,484 | €6,013 | +€3,529 | +142% |
| Remuneration and social security | 454/9 | €2,484 | €6,013 | +€3,529 | +142% |
| Other amounts payable | 47/48 | €525 | €525 | = | 0.0% |
| Accrued charges and deferred income | 492/3 | €1,861 | €264 | -€1,598 | -85.8% |
| Remuneration, social security and pensions | 62 | €75,500 | €39,205 | -€36,295 | -48.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €20,280 | €84,808 | +€64,529 | +318% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €720 | €1,689 | +€969 | +135% |
| Other operating charges | 640/8 | €1,546 | €2,319 | +€774 | +50.1% |
| Gross operating margin | 9900 | €148,901 | €149,998 | +€1,098 | +0.7% |
| Operating profit (loss) | 9901 | €50,856 | €21,977 | -€28,879 | -56.8% |
| Financial income | 75/76B | €2,996 | €2,603 | -€392 | -13.1% |
| Recurring financial income | 75 | €2,996 | €2,603 | -€392 | -13.1% |
| Financial charges | 65/66B | €4,242 | €6,577 | +€2,335 | +55.0% |
| Recurring financial charges | 65 | €4,242 | €6,577 | +€2,335 | +55.0% |
| Profit (loss) for the period before taxes | 9903 | €49,609 | €18,003 | -€31,606 | -63.7% |
| Income taxes | 67/77 | €9,314 | €5,491 | -€3,822 | -41.0% |
| Profit (loss) for the period | 9904 | €40,295 | €12,512 | -€27,784 | -69.0% |
| Profit (loss) for the period to be appropriated | 9905 | €40,295 | €12,512 | -€27,784 | -69.0% |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.